Medicare Now Covers Breakthrough Technology To Treat Uncontrolled High Blood Pressure
Under the CMS coverage policy, patients experiencing a blood pressure higher than 140 systolic and 90 diastolic and have been on a drug therapy and lifestyle modification regimen for at least six weeks could qualify for Medicare coverage of renal denervation.
Medtronic Delivers on FY25 Sustainability Targets and Charts Path to 2030
Medtronic plc, a global healthcare technology leader, has released its fiscal year 2025 (FY25) Impact Report, “Unlocking the future of health,” detailing progress toward its impact goals.